Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Israel

Teva Initiates Generic Lamictal Sales

July 2008 | Company News Alert
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.

Teva Pharmaceutical has started commercial shipment of 25mg, 100mg, 150mg and 200mg doses of its generic version of Glaxosmithkline (GSK)'s Lamictal (lamotrigine) in the US.